Peter Sullivan

The insurer would pass discounts to patients at the pharmacy counter.

Extending the credits after Nov. 1 is still possible, experts say, but gets much harder if there are massive changes.

The measure targets a provision that Democrats say is a costly handout to major pharmaceutical companies.

The nine treatments that could be evaluated in one to two months under the streamlined process.

Sticker shock could lead many Americans to conclude health coverage is out of reach.

The vote shows how national security concerns are making their way into the health care sector.

The decision adds to conservative scrutiny of the agency and Commissioner Marty Makary.

The tax credits that help people afford premiums are at the center of the showdown over government funding.

The Trump administration is facing conflicting political pressures over Kennedy's recent move.

New rules around the drug could severely limit access in states with abortion bans.